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Summary 
Populations of murine peritoneal B-1 and splenic B-2 cells, highly purified by negative selection 
techniques, were used to demonstrate that B-1 cells completely fail to enter cell cycle in response 
to surface immunoglobulin M (slgM) crosslinking without any decrease in cell number or viability. 
This failure of B-1 cell responsiveness appears to represent a specific defect in sIgM-derived signaling 
inasmuch as stimulation to enter S phase occurs normally in response to activated and fixed T 
cells,  and to lipopolysaccharide (LPS). The level at which slgM signaling fails was determined 
by evaluating the nuclear expression of the transcription factor complex, NF-KB, whose slgM- 
mediated induction in B-2 cells is dependent on protein kinase C (PKC) activation but is independent 
of protein synthesis. There was no induction of nuclear NF-KB in B-1 cells stimulated by slgM 
crosslinking, although NF-KB was stimulated by phorbol myristate acetate and by LPS. In contrast, 
NF-IcB was induced in B-2 cells by all three stimuli. Thus, in B-1 cells, the slgM-mediated induction 
of a transcription factor that is substantially stimulated by anti-IgM in B-2 cells is blocked. However, 
all  slgM-derived signaling in B-1  cells was not impaired inasmuch as anti-IgM increased I-A 
antigen expression. These results strongly suggest that slgM receptor-mediated signaling in B-1 
cells is interrupted early in the signal transduction pathway, at a point proximal to the activation 
of PKC. These results further demonstrate that transcription factor induction can be used to 
analyze the level at which receptor-mediated signaling is blocked. 
eceptor-mediated induction of cell cycle progression is 
accompanied by alterations in gene expression that ap- 
pear to be brought about by tram-acting transcription factor 
complexes. Nuclear expression of one such complex, NF-KB, 
is stimulated early (within the first 2 h) after surface IgM 
(slgM) receptor crosslinking in primary, conventional B cells 
(1, 2), and this induction appears to be protein kinase C (PKC) 
dependent (1, and our unpublished observations). As shown 
by others, nuclear expression of NF-KB likely results from 
the PKC-mediated modification of an inhibitor (IKB) associated 
with NF-KB,  the NF-KB/IgB complex being constitutively 
present in the cytosol (3); thus, this factor represents a fairly 
direct path from receptor-mediated kinase activation to al- 
teration in gene expression that is not dependent on protein 
synthesis (1). 
B-1 cells (formerly termed Ly-1 + or CD5 § B cells) differ 
in many respects from conventional B  (B-2) cells and may 
represent a unique, early appearing lymphoid lineage (reviewed 
in reference 4). It has been suggested that, unlike B-2 cells, 
B-1 cells fail to progress in cell cycle in response to slgM cross- 
linking (5-8). However, these reports were based on studies 
using peritoneal B lymphocytes that were not depleted of 
"contaminating" conventional B cells or B-1 cells that were 
purified by positive selection for Ly-1 expression; the latter 
may have the potential to alter the normal responsiveness of 
these cells to other receptor-mediated signals. In the present 
work we have used peritoneal B-1 lymphocytes purified by 
negative sdection techniques to define the specificity and the 
extent of the slgM-mediated signaling defect in these cells. 
In particular, the induction of NF-KB was assessed to deter- 
mine whether the defect in sIgM signaling in B-1 cells lies 
proximally or distally to the receptor-mediated activation of 
PKC. 
Materials  and Methods 
Animals.  Male BALB/cByJ mice at 8-14 wk of age were ob- 
tained from The Jackson Laboratory (Bar Harbor, ME). Mice were 
rested at least  1 wk before experimentation. 
B Cell Purification.  B-1 lymphocytes were prepared  using a 
modification of previously described methods (9). Peritoneal wash- 
out cells were depleted of T cells with anti-Thy-l.2 plus rabbit com- 
plement, depleted ofmacrophages by overnight adherence to plastic, 
and depleted of residual macrophages and other nonlymphoid cells 
by sedimentation on discontinuous Percoll gradients (with densi- 
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of cells at the 1.069/1.08 interface. Conventional B cells were re- 
moved by incubation with biotin-coupled rat anti-mouse (RAM) 
CD23 and rat anti-mouse IgD  a (Pharmingen, San Diego, CA) in 
the presence  of rat gamma globulin (Jackson Immunoresearch,  West 
Grove, PA), followed by streptavidin magnetic particles (Advanced 
Magnetics, Cambridge, MA), and removal on a magnetic concen- 
trator (Dynal, Great Neck, NY). B-2 cells were similarly purified 
from BALB/cByJ  splenocytes, except that red blood cells were re- 
moved by hypotonic lysis using Gey's solution, the 1.069/1.08 and 
the 1.08/1.09 Percoll  interfaces were combined, and contaminating 
B-1 cells were removed with biotin-coupled rat anti-mouse Ly-1 
(Pharmingen) plus streptavidin magnetic particles. 
Flow Cytometry.  Cells were  labeled with  FITC-conjugated 
F(ab')2 goat anti-mouse (GaM)IgM (Jackson Immunoresearch) or 
PE-conjugated  F(ab')2  GaMIgM  (Jackson  Immunoresearch), 
FITC-F(ab')2 GaMIgD ~ (Pharmingen),  and either biotin-RaM- 
CD23 (Pharmingen) or biotin-RaM-CD5 (Pharmingen)  plus biotin- 
RaM-Mac-1 (kindly provided by Dr.  Henry H.  Wortis,  Tufts 
University School of Medicine, Boston, MA), followed by strep- 
tavidin(SA)-PE (Pharmingen), as previously described (10). Non- 
viable cells were eliminated by gating on the basis of propidium 
iodide exclusion. Quadrant analysis  for spedficaUy  stained cell popu- 
lations was carried out on the basis of <2% nonspecific staining 
with biotin-RaM-CD8 (Pharmingen) plus SA-PE as a negative an- 
tibody control. 
Measurement of Stimulatory Responses.  Proliferative assays were 
carried out as previously described (11) using 10  s B cells/culture. 
Murine T ceils (CDC35 Th2 clone) were kindly provided by Dr. 
David C.  Parker (University of Massachusetts Medical School, 
Worcester, MA). T cells were activated by solid phase anti-CD3 
antibody and fixed with formaldehyde as described (12). 
Electrophoretic  Mobility Shift Assays (EMSA).  Nuclear gB-binding 
activity was detected by the electrophoretic gel mobility shift assay 
as previously described (1), except that nucleoprotein complexes 
were separated on 4% native polyacrylamide gels. rB-binding ac- 
tivity was quantitated by densitometric scanning of autoradiograms 
(Molecular Dynamics, Sunnyvale, CA). 
Reagents.  PMA and LPS (Escherichia  coli, serotype  0127:B8) were 
obtained from Sigma Chemical Co.  (St. Louis, MO).  Affinity 
purified  F(ab')2  GaMIgM  was  obtained  from Jackson  Im- 
munoresearch. PercoU  was obtained from Pharmacia Fine Chem- 
icals (Piscataway, NJ). 
Results and Discussion 
Purification of B-1 and B-2 Cell Populations.  Purified B-1 
cells were derived from peritoneal B lymphocytes by deple- 
tion of"contaminating" conventional B (B-2) cells using nega- 
tive selection techniques based on the marked variation in 
expression of CD23  and slgD between these populations, 
as described in Materials and Methods. Purified B-2 cells were 
obtained from splenic B lymphocytes by depletion of Ly-1 + 
cells. The purity of these two B cell populations was assessed 
by histologic examination of cytocentrifuge preparations and 
by flow cytometric analysis  of surface antigen expression. 
Purified B-1 cells were found to be >99% lymphocytes and 
<0.5% macrophages, neutrophils, and basophils.  These cells 
were >99%  slgM + and 94%  positive after staining with 
anti-Ly-1 plus anti-Mac-1 (Fig.  1 A). Another 4% consisted 
of cells that were Ly-1- and Mac-l- but expressed levels of 
slgM >99% of conventional B cells. Thus, at least 94% of 
the B-1 population represents either B-la or B-lb ("sister") 
cells, and (on the basis of high-density slgM expression) the 
B-1 population may be 98%  pure. Purified B-2 cells were 
found to be >99%  slgM +  and predominantly CD23  ex- 
pressing (87%)  and slgD  ~. 
Characterization orB-1 Stimulatory Responses.  The responses 
of these purified populations were assessed by measuring the 
incorporation of [~H]thymidine after treatment with various 
mitogens. B-1 cells completely failed to respond to several 
doses of anti-IgM that were fully stimuhtory for B-2 cells 
(Fig. 1 B), while viability was not affected (Table 1). B-1 ceils 
were not inert to stimulation, however, as they responded 
vigorously to PMA, which, as shown previously, is a sufficient 
mitogen for B-l, but not B-2,  cells (10,  11). B-1  and B-2 
cells responded well to LPS stimulation, and further, the two 
B cell populations responded comparably to stimulation by 
activated and fixed T cells (Fig.  1 C), which has been shown 
to involve a specific ligand/receptor (p39/CD40) interaction 
(12, 13). These results verify the existence of a defect in sIgM- 
mediated signaling using negatively selected B-1 ceUs that 
are virtually devoid of B-2 cells and are not subject to the 
potentially confounding influence of CD5 ligation. Moreover, 
the lack of S phase entry in response to anti-IgM is shown 
here to represent a block in B-1 cell signaling that is specific 
for and restricted to the sIgM receptor. 
Abnormal Induction of Nuclear NF-rB Expression in B-I Lym- 
phocytes.  In peritoneal B cells sIgM crosslinking leads to a 
seemingly contradictory increase in intraceUular Ca  2+  (14, 
15) without an apparent increase in inositol phosphate gener- 
ation (our unpublished observations). To clarify the level at 
which slgM signaling is blocked, the slgM-mediated induc- 
tion of nuclear NF-rB was evaluated. We reasoned that if 
transcription  factor  induction  is  normal  (conventional B 
cell-like), then the defect in slgM signaling is likely to be 
located downstream, perhaps within the genome (e.g., due 
to methylation of a gene that is normally expressed after an- 
tigen receptor crosslinking); whereas if transcription factor 
induction is abnormal, then the defect likely lies between sIgM 
and PKC-mediated phosphorylation. 
The EMSA was used to detect NF-KB with a rB-containing 
oligonudeotide (1). There was little or no induction of nu- 
clear xB-binding activity in B-1 calls after crosslinking of 
slgM (Figs. 2 and 3). However, rB-binding activity was effec- 
tively induced in B-1 cells by PMA and by LPS.  In direct 
and marked contrast, sIgM ligation mediated rapid induc- 
tion of rB-binding activity in B-2 cells, with a peak at 2-4 h, 
as did PMA and LPS. Although there was less PMA-induced 
rB-binding activity in B-1 as opposed to B-2 cells in some 
experiments, induction over respective baseline values  was 
similar in the two B cell populations,  owing to the lower 
constitutive expression of NF-rB in B-1 cells when similar 
quantities of nuclear-extracted protein were evaluated. To con- 
trol for variation in the absolute level of PMA-induced rB- 
binding activity between the two B cell populations,  KB- 
binding activity observed after treatment with anti-IgM was 
expressed as a proportion of that stimulated by PMA. In B-1 
858  Transcription  Factor Induction in B-1 Lymphocytes Figure  1.  (A) Phenotypic  analysis of purified B-1 and B-2 cells. Purified B-1 and B-2 cells were labeled with fluorescent antibodies as indicated, 
and analyzed by flow cytometry as described in Materials and Methods. (/3) S phase entry of B-1 and B-2 cells. Purified B-1 and B-2 cells were stimulated 
with PMA (100-300 ng/ml) for 24 h  or F(ab')2 fragments  of GaMIgM (2.5-10/~g/ml) for 48 h.  (C) S phase entry of B-1 and B-2 cells. Purified 
B-1 and B-2 cells were stimulated with P(ab')2 GaMIgM (10/~g/ml),  LPS (12.5 and 25/~g/ml), and either fixed nonactivated T cells (NATL-') or fixed 
activated T  cells (AGE') at a 1:1 (T/B) ratio, for 48 h. In B and C, [3H]TdR  incorporation during the last 6 h of culture was measured. These data 
are presented as the mean +  SEM of quadruplicate cultures reported  as cpm (x 10- 3). All data presented are representative of at least three separate 
experiments. 
cells, gB-binding activity in the presence of anti-IgM (no in- 
duction) amounted to only one-fourth to one-fifth of that 
stimulated by PMA at 2 h  (0.26  +_  0.06, n  =  5) and at 4 h 
(0.20  +  0.03, n  =  4), while in B-2 cells, anti-IgM produced 
levels of KB-binding activity that were equal to those stimu- 
lated by PMA at 2 h  (1.06  +  0.09, n  =  5) and at 4 h  (1.03 
+_  0.08,  n  =  4),  as determined by densitometry. 
To rule out the possibility that the peak of induced KB- 
binding activity was shifted in B-1 cells, additional experi- 
ments were carried out that included shorter and longer ex- 
posures to anti-IgM.  In addition to the time points shown 
(Fig. 3), there was no slgM-mediated induction of KB-binding 
activity in B-1 cells after 0.5 h of stimulation (data not shown). 
Constitutive and inducible KB-binding activity in B-1 and 
B-2 cells was appropriately competed by wild-type, but not 
by mutated, r,B-containing oligonucleotide (data not shown). 
This, along with the electrophoretic mobility of the nucleo- 
protein comple:~es, suggests that the activity detected by EMSA 
represents  NF-KB. 
These results indicate that NF-gB is capable of nuclear trans- 
location and induction in B-1 cells after direct PKC activa- 
tion (by PMA) or through a non-PKC-dependent pathway 
(by LPS), but not as a result of slgM crosslinking. Since in 
B-2 cells slgM-mediated induction of nuclear NF-xB is PKC 
dependent,  this strongly implies that  slgM-derived  signals 
fail to  adequately activate PKC in B-1  cells. 
Induction of MHC Class II (I-A) Antigen Expression by 13-I 
Lymphocytes.  To  determine  whether  all  forms  of  slgM- 
mediated signaling are blocked in B-1 cells, additional studies 
were conducted to evaluate the expression of class II MHC 
(I-A) antigens by flow cytometry. In contrast to a previous 
report  on unseparated peritoneal B  cells,  purified B-1 cells 
were found to express higher basal levels of surface I-A than 
B-2 cells (16). After stimulation with anti-IgM for 24 h, the 
level of B-1 I-A expression increased (Table 1). The increase 
in I-A expression was similar to that induced by IL-4 and by 
PMA in B-1 cells, but in three separate experiments was less 
than the increase induced in B-2 cells by these same reagents. 
This effect however, was not specific for slgM-derived signals, 
and thus likely reflects intrinsic differences in induction of 
I-A antigen expression between the two B cell populations. 
Further evidence that the slgM receptor of B-1 cells is not 
inert lies in our recent observation that anti-IgM stimulates 
similar patterns of protein tyrosine phosphorylation as that 
seen  in  B-2  cells  (our  unpublished  observations),  and  in 
previous reports  that  receptor ligation leads to changes in 
intracellular C# + (14,  15) and to antigen presentation (17). 
Thus, the failure of intracellular signaling is not only a de- 
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B-1 and B-2 Cells 
Median 
Cell  fluorescence 
Exp.  Treatment  viability  intensity (MFI) 
B-1 
B-2 
AMFI 
% 
Medium  87  661  - 
PMA  94  717  56 
IL-4  86  721  60 
Anti-IgM  89  705  44 
Medium  90  686  - 
Anti-IgM  84  751  67 
Medium  73  564  - 
PMA  81  657  93 
IL-4  77  655  91 
Anti-IgM  54  679  115 
Medium  73  598  - 
Anti-IgM  76  721  123 
B-1 and B-2 lymphocytes were cultured at 2  ￿  10  e cells/ml in medium 
alone  or medium containing PMA  (50  ng/ml), IL-4  (50  U/ml),  or 
F(ab')2 GaMIgM (10/~g/ml) for 24 h. Cells were harvested and labeled 
with anti-l-A  a and analyzed by flow cytometry as described in Materi- 
als and Methods.  Data are summarized and presented as the difference 
(A) in median fluorescence intensity (MFI) between stimulated and un- 
stimulated cells. The viability of recovered cells was assessed by trypan 
blue dye exclusion.  Two representative  studies are presented. 
Figure 2.  Induction  of nuclear r.B-binding  activity in B-1 and B-2 lym- 
phocytes. Purified B-1 (A) and B-2 (B) cells were cultured (4  x  10e/ml) 
in the presence of medium alone (214) or medium containing  either F(ab')2 
GaMIgM (algM; 10 #g/ml), PMA (200 ng/ml), or LPS (25 #g/ml) for 
2 and 4 h. Cells were washed and nuclear extracts prepared as previously 
described (1). Extracts were tested by EMSA using a gB-containing oligo- 
nucleotide probe. The data presented are representative of four separate 
experiments, including the data shown in Fig. 3. 
fect specific  to B-1 cell slgM, it appears to be specific  for slgM- 
derived signals  that lead to proliferation. 
Cell viability was assessed in connection with phenotypic 
evaluation by determining the trypan blue dye exclusion of 
recovered cells. As shown in Table 1, the viability of B-1 cells 
was not affected  by anti-IgM treatment, and viable cell recovery 
of anti-IgM-treated B-1 cells was, in fact, greater than that 
observed for B-2 cells. Thus, there is no evidence that slgM 
crosslinking by F(ab')2 fragments of anti-IgM antibodies in 
vitro is deleterious for B-1 cells. Although this contrasts with 
Figure 3.  Induction of  slgM- 
mediated  nuclear  loB-binding ac- 
tivity in B-1 and B-2 lymphocytes. 
Purified B-1 (.4) and B-2 (B) cells 
were cultured in  the presence of 
medium alone (M) or medium con- 
taining  either  F(ab~  GaMIgM 
(algM; 10/~g/ml),  for 1, 2, 4, and 
6 h, or PMA (200 ng/ml) for 2 and 
4 h. Nuclear extracts were prepared 
and analyzed as described in Fig. 2. 
860  Transcription Factor Induction in B-1 Lymphocytes the report that  antigen-mediated  slgM interaction leads to 
apoptosis of B-1 cells (18),  that report is inconsistent with 
the observation that B-1 cells are not tolerizable as a result 
of slgM crosslinking (15), and it may be that the apoptosis 
observed by Murakami et al. (18) involves additional cytokine- 
mediated influences or FcR-mediated signaling resulting from 
antigen-bound  autoantibody. 
The present  work demonstrates  that  a specific  defect in 
slgM signaling for proliferation exists in B-1 cells and that 
this defect is associated with an inability to properly stimu- 
late nuclear translocation of a constitutively expressed trans- 
acting transcription  factor whose induction is normally de- 
pendent on PKC. This strongly suggests that  the block in 
B-1 slgM-mediated  signaling  occurs at a level proximal to 
the activation of PKC, a conclusion supported by the obser- 
vation that direct stimulation of PKC leads to strong induc- 
tion  of NFqcB in B-1 cells. 
At this point it cannot be said that the failure of NF-KB 
induction is responsible for the lack orB-1 cell cycle progres- 
sion; however, the analysis of transcription factor induction 
described herein provided the means to localize the level of 
defective slgM signaling by focusing on a physiological out- 
come of receptor-mediated kinase activation. This approach 
may be generally applicable to the dissection of other defects 
in receptor-mediated  immune  cell responsiveness. 
Despite the common occurrence of autoreactive antigen 
receptors, B-1 cells are not unduly expanded in vivo under 
normal conditions.  Thus,  the block in slgM-mediated sig- 
naling as characterized in this report may be a physiological 
mechanism  that  prevents untoward stimulation  and clonal 
expansion  of B-1 cells by autologous antigen  in vivo. 
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